Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018.

Authors:
Osipenko L; Potey P; Perez B; Kupryjanczuk A; Angelov F and 2 more

Journal:
JAMA Intern Med

Publication Year: 2024

DOI:
10.1001/jamainternmed.2023.6249

PMCID:
PMC10660249

PMID:
37983026

View on PubMed View on PMC View Publisher
Journal Information

Full Title: JAMA Intern Med

Abbreviation: JAMA Intern Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Internal Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking…
Lin HX; Liu Z; Hajek P and 9 more (2024) - Transparency Score: 2/6
Photobiomodulation Therapy to Treat Snakebites Caused by Bothrops atrox: A Randomized Clinical Tria…
Carvalho ÉDS; Souza ARDN; Melo DFC and 17 more (2024) - Transparency Score: 2/6
Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.
Cesta CE; Rotem R; Bateman BT and 12 more (2024) - Transparency Score: 1/6
A Statewide Quality Initiative to Reduce Unnecessary Antibiotic Treatment of Asymptomatic Bacteriur…
Vaughn VM; Gupta A; Petty LA and 14 more (2023) - Transparency Score: 1/6
Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin Lymphoma: A …
Banerjee T; Kim MS; Haslam A and 1 more (2023) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"our data set that references the origins of specific medicines included in this study is available in the public open-source repository on zenodo and can be rechecked and corrected should more accurate information be identified by other researchers."

Code Sharing
COI Disclosure
Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025